Výsledky vyhledávání - Erin Macrae
- Zobrazuji výsledky 1 - 8 z 8
-
1
-
2
Use and Duration of Chemotherapy in Patients With Metastatic Breast Cancer According to Tumor Subtype and Line of Therapy Autor Davinia Seah, Inês Vaz-Luís, Erin Macrae, Jessica Sohl, Georgia Litsas, Eric P. Winer, Nancy U. Lin, Harold J. Burstein
Vydáno 2014Artigo -
3
Neoadjuvant Dual HER2-Targeted Therapy With Lapatinib and Trastuzumab Improves Pathologic Complete Response in Patients With Early Stage HER2-Positive Breast Cancer: A Meta-Analysi... Autor Mellissa Hicks, Erin Macrae, Mahmoud Abdel‐Rasoul, Rachel M. Layman, Susan Friedman, Jenny Querry, Maryam B. Lustberg, Bhuvaneswari Ramaswamy, Ewa Mrózek, Charles L. Shapiro, Robert Wesolowski
Vydáno 2015Revisão -
4
Endocrine Treatment and Targeted Therapy for Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer: ASCO Guideline Update Autor Harold J. Burstein, Mark R. Somerfield, Debra L. Barton, Ali Dorris, Lesley Fallowfield, Dharamvir Jain, Stephen Johnston, Larissa A. Korde, Jennifer K. Litton, Erin Macrae, Lindsay L. Peterson, Praveen Vikas, Rachel L. Yung, Hope S. Rugo
Vydáno 2021Revisão -
5
Endocrine Therapy for Hormone Receptor–Positive Metastatic Breast Cancer: American Society of Clinical Oncology Guideline Autor Hope S. Rugo, R. Bryan Rumble, Erin Macrae, Debra L. Barton, Hannah Connolly, Maura N. Dickler, Lesley Fallowfield, Barbara Fowble, James N. Ingle, Mohammad Jahanzeb, Stephen Johnston, Larissa A. Korde, James Khatcheressian, Rita S. Mehta, Hyman B. Muss, Harold J. Burstein
Vydáno 2016Artigo -
6
Heterogeneous atypical cell populations are present in blood of metastatic breast cancer patients Autor Maryam B. Lustberg, Priya Balasubramanian, Brandon Miller, Alejandra Garcia-Villa, Clayton Deighan, Yongqi Wu, Sarah Carothers, Michael Berger, Bhuvaneswari Ramaswamy, Erin Macrae, Robert Wesolowski, Rachel M. Layman, Ewa Mrózek, Xueliang Pan, Thomas A. Summers, Charles L. Shapiro, Jeffrey J. Chalmers
Vydáno 2014Artigo -
7
Circulating myeloid-derived suppressor cells increase in patients undergoing neo-adjuvant chemotherapy for breast cancer Autor Robert Wesolowski, Megan Duggan, Andrew Stiff, Joseph Markowitz, Prashant Trikha, Kala Levine, Lynn Schoenfield, Mahmoud Abdel‐Rasoul, Rachel M. Layman, Bhuvaneswari Ramaswamy, Erin Macrae, Maryam B. Lustberg, Raquel E. Reinbolt, Ewa Mrózek, John C. Byrd, Michael A. Caligiuri, Thomas A. Mace, William E. Carson
Vydáno 2017Artigo -
8
Dabrafenib and Trametinib in Patients With Tumors With <i>BRAF<sup>V600E</sup></i> Mutations: Results of the NCI-MATCH Trial Subprotocol H Autor April K.S. Salama, Shuli Li, Erin Macrae, Jong–In Park, Edith P. Mitchell, James A. Zwiebel, Helen X. Chen, Robert J. Gray, Lisa M. McShane, Larry Rubinstein, David R. Patton, P. Mickey Williams, Stanley R. Hamilton, Deborah K. Armstrong, Barbara A. Conley, Carlos L. Arteaga, Lyndsay N. Harris, Peter J. O’Dwyer, Alice P. Chen, Keith T. Flaherty
Vydáno 2020Artigo
Vyhledávací nástroje:
Související témata
Cancer
Internal medicine
Medicine
Breast cancer
Oncology
Metastatic breast cancer
Chemotherapy
Biology
Cancer research
Clinical trial
Adjuvant
Immunology
Lapatinib
Pathology
Targeted therapy
Trastuzumab
Adjuvant chemotherapy
Antibody
Antibody-drug conjugate
Aromatase inhibitor
Art
CA15-3
Cell biology
Circulating tumor cell
Clinical endpoint
Complete response
DAPI
Dabrafenib
Duration (music)
Endocrine system